NCT04987606View on ClinicalTrials.gov

Post COVID-19 Interstitial Lung Disease: A Study of Genetic and Environmental Interactions

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

April 1, 2023

Study Completion Date

April 1, 2024

Conditions
Pulmonary FibrosisCOVID-19 Pneumonia
Trial Locations (4)

NW1 2PG

University College London NHS Foundation Trust, London

SW3 6NP

Royal Brompton Hospital, London

W2 1BL

Imperial College Healthcare Trust, London

M13 9WL

Manchester University NHS Trust, Manchester

All Listed Sponsors
lead

Imperial College London

OTHER